Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4513 |
id |
doaj-127554525125483faa9d05a1818c51fb |
---|---|
record_format |
Article |
spelling |
doaj-127554525125483faa9d05a1818c51fb2021-07-29T07:58:46ZengWileyClinical Case Reports2050-09042021-07-0197n/an/a10.1002/ccr3.4513Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case seriesNissar Shaikh0Mohamad Y. Khatib1Mohammad A. Alwraidat2Dore C. Ananthegowda3Muftah Othman4Asra Aroos5Sagar B. Jujjavarapu6Saptarshi Banerjee7Zishan Nasir8Ahmed S. Mohamed9Moustafa S. Elshafei10Muna A. Almaslamani11Abdulqadir J. Nashwan12Surgical Intensive Care Department Hamad General Hospital (HGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarCommunicable Diseases Center (CDC) Hamad Medical Corporation (HMC) Doha QatarMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha QatarAbstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit.https://doi.org/10.1002/ccr3.4513acute kidney injuryCOVID‐19 infectionend‐stage renal diseasehypertensionimmunosuppressionrenal transplant |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nissar Shaikh Mohamad Y. Khatib Mohammad A. Alwraidat Dore C. Ananthegowda Muftah Othman Asra Aroos Sagar B. Jujjavarapu Saptarshi Banerjee Zishan Nasir Ahmed S. Mohamed Moustafa S. Elshafei Muna A. Almaslamani Abdulqadir J. Nashwan |
spellingShingle |
Nissar Shaikh Mohamad Y. Khatib Mohammad A. Alwraidat Dore C. Ananthegowda Muftah Othman Asra Aroos Sagar B. Jujjavarapu Saptarshi Banerjee Zishan Nasir Ahmed S. Mohamed Moustafa S. Elshafei Muna A. Almaslamani Abdulqadir J. Nashwan Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series Clinical Case Reports acute kidney injury COVID‐19 infection end‐stage renal disease hypertension immunosuppression renal transplant |
author_facet |
Nissar Shaikh Mohamad Y. Khatib Mohammad A. Alwraidat Dore C. Ananthegowda Muftah Othman Asra Aroos Sagar B. Jujjavarapu Saptarshi Banerjee Zishan Nasir Ahmed S. Mohamed Moustafa S. Elshafei Muna A. Almaslamani Abdulqadir J. Nashwan |
author_sort |
Nissar Shaikh |
title |
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series |
title_short |
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series |
title_full |
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series |
title_fullStr |
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series |
title_full_unstemmed |
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series |
title_sort |
clinical outcomes of post‐renal transplant patients with covid‐19 infection in the icu: a single‐center case series |
publisher |
Wiley |
series |
Clinical Case Reports |
issn |
2050-0904 |
publishDate |
2021-07-01 |
description |
Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit. |
topic |
acute kidney injury COVID‐19 infection end‐stage renal disease hypertension immunosuppression renal transplant |
url |
https://doi.org/10.1002/ccr3.4513 |
work_keys_str_mv |
AT nissarshaikh clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT mohamadykhatib clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT mohammadaalwraidat clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT dorecananthegowda clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT muftahothman clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT asraaroos clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT sagarbjujjavarapu clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT saptarshibanerjee clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT zishannasir clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT ahmedsmohamed clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT moustafaselshafei clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT munaaalmaslamani clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries AT abdulqadirjnashwan clinicaloutcomesofpostrenaltransplantpatientswithcovid19infectionintheicuasinglecentercaseseries |
_version_ |
1721259119749365760 |